MAY 13, 2020 3:44 PM PDT

Drug Targets Off Episodes of Parkinson

WRITTEN BY: Nouran Amin

A novel drug was approved by the FDA to target the “off” episodes of Parkinson disease. The drug is referred to as ‘Ongentys’ which is a catechol-o-methyltransferase (COMT) inhibitor that when combined with another drug improves treatment efficacy. In other words, Ongentys works with levodopa to increase more dopamine entry into the brain.

Learn more about Parkinson:

Dopamine is brain fuel that stimulates normal movements and decreases symptoms associated with Parkinson.

Learn more about dopamine:

Some adverse effects associated with Ongentys use includes abnormal dreams, headaches, sleep challenges, hallucinations, and low blood pressure. Although some complications, such as dyskinesia (involuntary movements), is related to levodopa boost rather than Ongentys alone.

Source: MichaelJFox.org

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
MAY 04, 2020
Immunology
MAY 04, 2020
GeoVax and Sino Bio Collaborate on COVID-19 Vaccine Work
GeoVax Labs, Inc., a biotechnology company developing human vaccines and immunotherapies against infectious diseases and ...
JUN 03, 2020
Cannabis Sciences
JUN 03, 2020
CBD Oil May Treat and Prevent Acne
Cannabidiol (CBD) is a compound found in cannabis. Known for its relaxing effects, some research also suggests that it m ...
JUN 06, 2020
Cancer
JUN 06, 2020
Developing a Platform to Efficiently Test Antibody-Drug Conjugates
Cancer has been one of the most persistent diseases modern medicine has faced. Due to its nature, treatments are often t ...
JUN 15, 2020
Cancer
JUN 15, 2020
Using miRNA to Treat Cancer Stem Cells
In many cancers, there exists a type of cancer cell called a cancer stem cell.  These are cells that, after chemoth ...
JUN 26, 2020
Cancer
JUN 26, 2020
Combining Treatments to Improve Acute Myeloid Leukemia Therapy
Acute myeloid leukemia (AML) is a type of blood cancer that prevents the complete maturation of stem cells. These immatu ...
JUN 25, 2020
Cell & Molecular Biology
JUN 25, 2020
Peptide Made by Marine Worms Can Destroy Multidrug-Resistant Bacteria
Drug-resistant bacteria pose a serious threat to public health, and scientists have been searching for new antibiotics t ...
Loading Comments...